These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4307990)

  • 21. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutagenic alkylating agents as growth inhibitors and carcinogens.
    Koller PC
    Mutat Res; 1969; 8(1):199-206. PubMed ID: 5796941
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduction of the toxicity of radiomimetic alkylating agents in rats by thiol pretreatment. V. The effect of thiol pretreatment on the anti-tumour action of Merophan.
    Connors TA; Jenney A; Whisson ME
    Biochem Pharmacol; 1965 Nov; 14(11):1681-3. PubMed ID: 5867521
    [No Abstract]   [Full Text] [Related]  

  • 25. Antineoplastic action of methylglyoxal.
    Jerzykowski T; Matuszewski W; Otrzonsek N; Winter R
    Neoplasma; 1970; 17(1):25-35. PubMed ID: 4315796
    [No Abstract]   [Full Text] [Related]  

  • 26. POTENTIAL ANTICANCER AGENTS. LXXX. ALKYLATING AGENTS RELATED TO PHENYLALANINE MUSTARD. VI. ENANTIOMERIC META-PHENYLALANINE MUSTARDS.
    GRAM HF; BERRIDGE BJ; ACTON EM; GOODMAN L
    J Med Chem; 1963 Jan; 6():85-7. PubMed ID: 14174040
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential carcinolytic agents. V. Enamine mustards.
    Papanastassiou ZB; Bruni RJ; White E
    J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of growth of ascites hepatoma and Yoshida sarcoma in rats and changes caused by nitromin treatment.
    KONO O; TERASHIMA H; AZUMA S; MURATA Y
    Gan; 1954 Sep; 45(2-3):536-8. PubMed ID: 13220977
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental studies on the tumour inhibitory effect of heparin-degranol (Zitofenton).
    Németh L
    Neoplasma; 1969; 16(2):137-43. PubMed ID: 4185312
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of macromolecules upon the rates of hydrolysis of aromatic nitrogen mustard derivatives.
    Hopwood WJ; Stock JA
    Chem Biol Interact; 1971 Dec; 4(1):31-9. PubMed ID: 5156335
    [No Abstract]   [Full Text] [Related]  

  • 32. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antitumor activity of adriamycin].
    Kitaura K; Watanabe Y; Ishihara Y; Takahira H
    Jpn J Antibiot; 1972 Apr; 25(2):65-71. PubMed ID: 4341940
    [No Abstract]   [Full Text] [Related]  

  • 34. [Toxicity and antineoplastic activity of a new thio-TEPA analog].
    Konovalova NP; D'iachkovskaia RF; Kiseleva EG
    Vopr Onkol; 1973; 19(1):58-63. PubMed ID: 4349733
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential anticancer agents. V. New aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid.
    Cambanis A; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1969 Jan; 12(1):161-4. PubMed ID: 5763014
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitumor activity of tilorone hydrochloride against some rodent tumors: preliminary report.
    Adamson RH
    J Natl Cancer Inst; 1971 Feb; 46(2):431-4. PubMed ID: 4329959
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 38. [THE INFLUENCE ON CARBOHYDRATE METABOLISM OF TUMORS OF CHOMOTHERAPEUTIC DRUGS].
    KROEGER H
    Z Naturwiss Med Grundlagenforsch; 1963 Apr; 1():126-42. PubMed ID: 14159165
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro test for sensitivity of tumor to carcinostatic agents.
    Kondo T; Imamura T; Ichihashi H
    Gan; 1966 Apr; 57(2):113-21. PubMed ID: 4289605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.